ClinicalTrials.gov
public full text
Public Domain
Administration of Intranasal Midazolam for Anxiety in Palliative Care
The goal of this double-blind, randomized, placebo-controlled parallel-group multicenter exploratory pilot study (three study arms) is to describe effects and safety of different doses of intranasal midazolam to treat acute anxiety in palliative care patients, while providing pharmacokinetic and pharmacodynamic data.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit#807127
- Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia#861269
- Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs#1031644
- Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting#863510
- Evaluation of Touch Massage on Anxiety in Critically Ill Patients#1171364
Record · ID 837919
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive